Close Menu

Join or Log in for Access

This content is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Many targeted NGS-based panels have recently been introduced to detect RNA fusions useful for prognosis and therapy selection in cancer. Understanding the lower limits of detection (LOD) and the reproducibility across the reportable range of these assays is important for clinical adoption and regulatory compliance. However, there are few tools available to assess LOD. We generated an RNA panel that represents decreasing levels of 16 different RNA fusions and exam skipping events compared to the total cellular RNA.

Sponsored by

Nature News reports that researchers in Japan hope to soon test the use of reprogrammed stem cells to treat damaged corneas.

A new approach may help limit the number of fish that are mislabeled at markets or restaurants, according to New Scientist.

At Slate, the R Street Institute's Nila Bala discusses the privacy rights of suspects that genetic genealogy approaches in law enforcement bring up.

In PNAS this week: numerous mobile genetic elements contribute to Vibrio cholerae drug resistance, troponin I mutations in sudden infant deaths, and more.